Moehs Group, a reference company in the production of pharmaceutical active ingredients.
01 1Moehs Catalana SL
02 1Olpha AS
03 1Anonima Materie Sintetiche and Affini (AMSA) Spa
04 1LETCO MEDICAL, LLC
05 1Medisca Inc.
06 1Professional Compounding Centers of America dba PCCA
07 1Spectrum Chemicals and Laboratory Products
08 1Willow Birch Pharma, Inc.
09 1Zhejiang Apeloa Kangyu Pharmaceutical Co., Ltd.
01 3AMANTADINE HYDROCHLORIDE
02 6Amantadine Hydrochloride
01 1China
02 1Italy
03 1Latvia
04 1Spain
05 4U.S.A
06 1United Kingdom
Moehs Group, a reference company in the production of pharmaceutical active ingredients.
NDC Package Code : 52932-0707
Start Marketing Date : 2009-09-29
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
Olpha, a JSC AB City subsidiary, is a leading Baltic firm with 50 years of experience in medicines & chemical pharmaceuticals.
NDC Package Code : 63818-0435
Start Marketing Date : 2016-05-05
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT FOR HUMAN P...
NDC Package Code : 17373-1446
Start Marketing Date : 2014-10-27
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 62991-2559
Start Marketing Date : 2012-02-07
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT FOR HUMAN P...
NDC Package Code : 38779-0411
Start Marketing Date : 2013-01-29
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT FOR HUMAN P...
NDC Package Code : 51927-1754
Start Marketing Date : 2013-06-20
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT FOR HUMAN P...
NDC Package Code : 49452-0395
Start Marketing Date : 1994-05-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT
NDC Package Code : 10695-014
Start Marketing Date : 2016-07-11
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 66653-003
Start Marketing Date : 2016-05-27
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
A Amantadine manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Amantadine, including repackagers and relabelers. The FDA regulates Amantadine manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Amantadine API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Amantadine manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Amantadine supplier is an individual or a company that provides Amantadine active pharmaceutical ingredient (API) or Amantadine finished formulations upon request. The Amantadine suppliers may include Amantadine API manufacturers, exporters, distributors and traders.
click here to find a list of Amantadine suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Amantadine as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Amantadine API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Amantadine as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Amantadine and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Amantadine NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Amantadine suppliers with NDC on PharmaCompass.
We have 9 companies offering Amantadine
Get in contact with the supplier of your choice:
LOOKING FOR A SUPPLIER?
